Medical Review Institute of America

What Medical Review Institute of America does

Medical Review Institute of America, LLC (MRIoA) is a privately held, PE-backed utilization management company founded in 1983 and headquartered in Salt Lake City, Utah. The company delivers independent, evidence-based clinical reviews through a nationwide network of 700+ board-certified physicians across 150+ specialties, supported by an internal clinical team and two proprietary web platforms — ClientTools for case submission and reporting and ReviewerTools for reviewer workflow. Services span prior authorization, specialty drug review, peer-to-peer consultations, appeals, and external independent review organization (IRO) determinations, sold via multi-year enterprise contracts to health plans, TPAs, PBMs, unions and Taft-Hartley funds, government entities, and at-risk provider groups.

MRIoA generates revenue primarily through managed-services and recurring enterprise contracts priced on a quote basis per organizational needs and review volume. The company maintains NCQA Utilization Management, URAC HUM, URAC IRO, HITRUST CSF, and SOC accreditations that function as regulatory prerequisites for many payer contracts. Operational scale includes 2.4 million reviews per year, 98% turnaround-time performance, 99% quality rate, and an 11-year average client tenure across 900+ healthcare organizations.

The company is currently in a post-investment scaling phase following Parthenon Capital's July 2024 strategic growth investment, with a recently installed healthcare-technology executive team and a May 2025 partnership with Elligint Health to integrate advanced analytics into the clinical review workflow. The stated strategic direction is to extend automation-enabled services, deepen value-based care support for at-risk providers, and evolve from pure clinical review toward a more data-driven, tech-enabled utilization management platform.

Name

Medical Review Institute of America

Legal name

Medical Review Institute of America, LLC

Website

https://mrioa.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

251–500 employees

Short description

MRIoA is a PE-backed utilization management company that delivers independent, evidence-based clinical reviews from a 700+ physician network to 900+ health plans, TPAs, PBMs, unions, government entities, and at-risk providers across the United States.

Ownership category

akta.pro rank

Product category

Healthcare Utilization Management Services

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000)

akta.pro primary industry

Second Opinion & Expert Medical Review Platforms (HLALADAI)

akta.pro secondary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Clinical review services
• Utilization management
• Independent medical review
• Prior authorization reviews
• Healthcare appeals review

Headquarters

HQ city

Salt Lake City

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Review Services: MRIoA provides independent, evidence-based clinical reviews from a nationwide network of licensed physicians, nurses, and pharmacists. Services include prior authorization reviews, appeals, peer-to-peer consultations, and external independent review organization (IRO) services for health plans, TPAs, and PBMs.
2. Utilization Management Solutions: Configurable programs for utilization management including prior authorization, specialty drug review, peer-to-peer consultation, and appeals. Delivered as ongoing service contracts with healthcare organizations.
3. Regulatory Guidance Services: Proactive compliance expertise and regulatory guidance helping healthcare organizations navigate changing federal and state regulations, reduce risk, and maintain audit readiness.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Medical Review Institute of America (MRIoA) is a clinically-driven, technology-enabled utilization management company that provides independent, evidence-based clinical reviews through a nationwide network of 700+ licensed physicians, nurses, and pharmacists covering 150+ specialties. Its core offerings include prior authorization reviews, specialty drug reviews, peer-to-peer consultations, appeals support, and external independent review organization (IRO) services delivered to health plans, TPAs, PBMs, unions, government entities, and at-risk provider groups. The company supplements reviews with proactive regulatory guidance and analytics-backed insights to help healthcare organizations ensure appropriate, cost-effective care.

Product overview

MRIoA is a clinically-driven, technology-enabled utilization management company offering expert clinical reviews, regulatory guidance, and actionable insights to healthcare organizations. Founded in 1983, the company operates as a unified platform combining Clinical Review Services (independent, evidence-based reviews from a 700+ physician network across 150+ specialties), Clinical Solutions (configurable programs for prior authorization, specialty drug review, appeals, and peer-to-peer consultations), and Regulatory Guidance (proactive compliance expertise). The company also provides specialized services for at-risk providers and union/Taft-Hartley health plans, supported by internal platforms (Client Tools and Reviewer Tools) and strategic partnerships like the Elligint Health Helios integration for enhanced data analytics.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Review Services

Quantifiable outcome

• 2.4 million reviews completed per year
• +4 more outcomes

Named customers6 records

Segments6 records

Ideal customer profiles6 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Elligint HealthstrategicTechnology or Integration · 13 May 2025Strategic collaboration to transform clinical decision-making through integration of Elligint's Helios intelligence platform with MRIoA's clinical expertise. The partnership aims to streamline medical review processes, improve prior authorization efficiency, and reduce administrative burdens for healthcare organizations by combining advanced data analytics with expert clinical insights.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Dane Street: Dane Street is a national independent medical review and peer review company serving payers, TPAs, and government entities with a network of board-certified physician reviewers across multiple specialties. It is one of MRIoA's closest direct competitors in the IRO/peer review market.
• AllMed Healthcare Management: AllMed provides independent medical review, peer review, and utilization management services to health plans, TPAs, and government organizations. It is a direct competitor to MRIoA in the IRO and specialty-matched clinical review space.
• MES Solutions: MES Solutions delivers peer review and independent medical review services for workers' compensation, disability, and group health. It overlaps with MRIoA on peer-to-peer reviews and utilization management for payers.
• MCMC Medical Consultants Management Company: MCMC provides independent medical review, utilization management, and disability management services for insurance carriers, employers, and government agencies. It is a direct competitor to MRIoA's external independent review (IRO) services.
• HealthHelp: HealthHelp is a specialty benefits management company that provides utilization management and clinical review services, with a focus on radiology, cardiology, oncology, and sleep medicine. It directly competes with MRIoA in specialty prior authorization review.
• Advanced Medical Reviews (AMR): AMR is an independent medical review company providing peer review, utilization management, and external review services to health plans and TPAs. It is a direct competitor to MRIoA's clinical review and IRO service lines.

Broad incumbents

• eviCore Healthcare: eviCore, part of Elevance Health, is one of the largest specialty utilization management and benefit management companies, providing prior authorization and clinical review across radiology, cardiology, oncology, and specialty pharmacy. It is a broad incumbent that competes with MRIoA across multiple utilization management lines.
• AIM Specialty Health: AIM Specialty Health, a subsidiary of Elevance Health, provides clinical appropriateness review and utilization management for specialty services. It is a large incumbent competitor to MRIoA in the utilization management space, particularly with payer-owned entities.
• Conduent Healthcare Utilization Management: Conduent provides business process services including healthcare utilization management and clinical review workflows for payers and government programs. It is a broad incumbent competing with MRIoA in outsourced utilization management services.
• Optum Health: Optum, part of UnitedHealth Group, operates one of the largest in-house utilization management and clinical review operations in the U.S. As a vertical integrator, Optum is both a potential client and a major competitive threat to MRIoA's payer-facing review services.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medical Review Institute of America